AXT's $66 Million Quarter Is Largely Booked; Margins And Capacity Ramp Are The Real Test

AXT enters its September-quarter report with an unusual advantage and an unusual problem. The advantage is that management told investors three months ago that roughly $66 million of revenue for the period was already secured, which takes much of the guesswork out of the top line. The problem is that the stock has fallen 14.4% since that upbeat report while the S&P 500 gained 3.3%, a gap of nearly 18 percentage points. When the headline number is largely spoken for, the market tends to judge the quarter on everything else: margins, the pace of the indium phosphide capacity build, and whether the forward targets hold.

Wall Street is looking for earnings of $0.30 per share on revenue of $66.1 million when the company reports after the close on October 29. That revenue figure sits essentially on top of management's secured amount and would represent growth of about 136% from the $28.0 million posted a year ago, when AXT was still losing money. The earnings bar deserves a closer look. Management guided to non-GAAP EPS of $0.30 to $0.32, while the consensus is framed on a GAAP basis, where results ran a couple of cents below the non-GAAP figure last quarter. The Earnings Whisper of $0.33 sits above both consensus and the top of the guided range, suggesting the more enthusiastic crowd expects AXT to clear its own outlook rather than simply meet it.

The most important operating question is gross margin. Last quarter's jump to 45% from roughly 30% in the prior quarter and the low 20s before that was the clearest sign that higher indium phosphide volumes are delivering real operating leverage, and management signaled it hopes to push margins into the 50s. A print at or above 45% would validate that the improvement was structural, driven by mix and utilization rather than a one-time benefit. Any slippage back toward the 30s would raise uncomfortable questions, especially if sluggish, lower-margin gallium arsenide and germanium products take a larger share of the mix.

The capacity story matters even more for the stock's longer arc. Management raised its exit-2026 indium phosphide run rate target to about $60 million per quarter and its exit-2027 goal to roughly $130 million, far above the earlier plan. Backlog was described as well over $100 million, and prepaid long-term agreements with Coherent and Casella, plus a newly announced Lumentum deal, underpin that demand. Investors should want evidence that backlog kept growing, that six-inch wafer production is advancing toward volume, and that the 2027 expansion remains on schedule. Any reiteration or further lift of those targets would reinforce the multi-year growth narrative; a softer tone would undercut it.

The risks flagged last quarter remain live swing factors. Export permits are still the gating item for shipments, and China laser demand, now more than half of revenue, makes timing in that region critical. The Tongmei listing, moved from Shanghai to Hong Kong, carries a $49 million investor redemption right that bears monitoring, though the company's roughly $749 million cash pile after its April offering makes that more an overhang than a threat. Customer concentration is also rising as a few large agreements grow in importance.

Sentiment has warmed slightly, with the bearish reading easing from about 12.7% to 8.0%, yet the stock trades at $57.09, below its 200-day moving average of $63.22 and much closer to its post-earnings low of $50.57 than its high near $98. That leaves room for relief if AXT delivers. Ultimately, the report will turn on whether margins and capacity milestones prove that last quarter's inflection was the start of a durable ramp rather than a single spectacular quarter.

This earnings preview was originally published on Earnings Whispers.

This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It was generated automatically, with the help of AI, from Earnings Whispers and company data, and checked by Earnings Whispers before publication.